Caricamento...
Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors
ABSTRACT: BACKGROUND: Monoclonal antibodies have become attractive clinical anti-cancer drugs in the last 3 decades due to their targeting specificity and suitable pharmacokinetic properties. Mesothelin is a tumor-associated antigen with limited expression in normal tissues. It is frequently over-ex...
Salvato in:
| Pubblicato in: | Clin Cancer Drugs |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Bentham Science Publishers
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5080863/ https://ncbi.nlm.nih.gov/pubmed/27853672 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/2212697X03666160218215744 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|